Pharmaceutical Technology Europe, Aug 1, 2014 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Aug 1, 2014
Editor's Comment
Tracking the Pulse of the Pharmaceutical Industry
By Adeline Siew, PhD
Pharmaceutical Technology Europe marks its 25th anniversary.
Regulatory Watch
Collaboration and Innovation in European Medicine Regulation
By Sean Milmo
The European Union has developed a system for evaluating, approving and monitoring the safety of medicines that has also encouraged innovation.
Industry Insider
No Signs of a Slowdown in Mergers
By Faiz Kermani
A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.
Special Features
Advances in the Pharmaceutical Industry Have Shaped Particle Sizing Technology
By Paul Davies , Paul Kippax
A diverse range of particle sizing solutions is available, from techniques for the characterization of complex formulations through to online PAT tools for real-time measurement.
Maturing Aseptic Technologies Create More Flexible Facilities
By Friedrich Haefele
Innovative therapeutic approaches beyond mAbs will require new methods for future facility construction.
Innovations and Future Trends in HPLC Column Technology
Developments in chromatography column technology to deliver greater efficiency, speed and inertness benefit the drug development process from discovery to manufacturing and quality control.
Quality by Design—a Fundamental Paradigm Shift in Pharmaceutical Manufacturing
By Charles N. Kettler
Quality by Design has initiated a paradigm shift in solid dose pharmaceutical manufacturing.
How Excipient Supplier Certification Helps Pharmaceutical Supply Chain in Europe
By Iain Moore
The EXCiPACT Certification Scheme ensures patient safety through supplier quality while minimising the audit burden and overall costs for assessing the excipient supply chain.
Outsourcing Grows in Europe
By Eric Langer
Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.
Supply-Chain Security of Pharmaceutical Starting Materials
By Frank Milek
IPEC Europe continues to promote the quality, safety and functionality of excipients used in pharmaceutical products.
Supply-Chain Security from a European Perspective
By Hubert Stückler
Global harmonisation would help improve supply-chain security and reduce the flow of falsified and sub-standard medicine into Europe.
Trends in Tablet Tooling
By Steve Deakin
Tool coatings are now seen as an acceptable means of solving production problems, such as sticking and corrosion, resulting in increased product yield.
Continuous Manufacturing—the Future of Pharmaceutical Manufacturing
By Trevor Page
Continuous manufacturing is key to the future of pharmaceutical manufacturing.
Technology and QbD Drive Pharma Development
By Chris Kilbee
Quality by design, process analytical technology, and high throughput screening have helped drive progress in pharmaceutical development.
Advances in Film Coating
By Ali R. Rajabi-Siahboomi
Film coating for solid oral dosage forms provide important patient benefits while enhancing brand recognition and adding value to innovator, generic, over-the-counter and nutritional products.
Polymers for Solubility Enhancement
By William Porter III
New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.
Pharmaceutical Manufacturing and Supply-Chain Trends to 2020
By Guy Villax
A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Tableting—a Focus for Continuous Improvement
By Tim Freeman
Efforts to tackle challenges in tablet manufacture are shaped by quality by design (QbD) and continuous manufacturing.
Past, Present and Future of Softgel Technologies
By Kaspar van den Dries
Softgels are now being recognised as one of the preferred dosage forms for the treatment of pain, eye conditions, cough and cold, as well as allergy.
Opportunities with Softgels
By Stephen Tindal
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.
Advances in Prefilled Syringe Manufacturing
Experts discuss developments and future trends in prefilled syringes.
Serialisation, Aggregation and Authentication
By Johannes Rauschnabel
Pharmaceutical manufacturers will be—and are already—facing enormous challenges to implement the serialization regulations within the given timeframe.
Protecting Drug Safety
By Rüdiger Manthey
In the past 10 years, safety issues have become increasingly important in pharmaceutical packaging, from needle sticking safety to counterfeit protection.
Single-Use and Continuous Processing Technologies Change Facility Design
By Günter Jagschies
Single use has introduced a level of flexibility into facilities that was either unheard of or very expensive in a stainless-steel environment.
Single-Use Systems: Enabling the Future of Biologics Manufacturing
By Michael Felo
Single-use technologies, which started off as a tool for small-volume solution storage and transport has now become the central, enabling technology around which manufacturing processes and facilities are being designed.
Single-Use: Game-Changing Technology for the Biopharmaceutical Industry
By Stefan Schlack
The success of new biopharmaceutical drugs also relies on innovative solutions such as single-use technologies that suppliers have to offer to the pharmaceutical industry.
Trends in Single-Use Biomanufacturing
By Dethardt Müller
Single-use technologies have gained broad acceptance in biomanufacturing within the past few years, supporting flexible and cost-effective clinical production.
Biosimilar Development: 10 Years On
By Fiona Greer
With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.
Emerging Opportunities with Biosimilars
By Virginia Acha
To realise the full potential for biosimilars, stakeholders must build a better understanding of biosimilars and to take a comprehensive view of how these important medicines can fit into treatment pathways.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here